drugset / Trial / NCT03188445

Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.

NCT03188445

Phase 4 Completed 201 enrolled Pharmacosmos A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy

Timeline

Start
2017-07-11
Primary completion
2020-06-26
Completion
2020-08-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric Derisomaltose Unknown 1000 mg Intravenous
Comparator Ferrous Sulfate Diagnostic / imaging agent 100 mg Oral
Comparator Vitamin C Other / unclassified 60 mg Oral